Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
US clinical-stage biotechnology company Rigel Pharmaceuticals has appointed Anne-Marie Duliege as its new chief medical officer, it has been announced. 9 March 2016
Privately-held Swiss biotech firm MaxiVAX SA has appointed Dimitrios Goundis as its chief executive. Dr Goundis joins the company after holding several senior management and R&D positions at The Medicines Company, Speedel and Roche, both in Europe and the USA. 8 February 2016
Gilead Sciences Inc on Friday said chief operating officer John Milligan will be promoted to chief executive, replacing the current chairman and CEO John Martin who will take on the role of executive chairman, both effective March 10, 2016. 29 January 2016
Austria-based biotechnology company Themis Bioscience on Tuesday announced the appointment of two new members to leadership roles, Philippe Dro and Christian Mandl. 19 January 2016
UK biotech firm Centauri Therapeutics said today it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies. 18 January 2016
Shares in US biotech firm Celgene Corp closed down over 5.5% on Nasdaq Monday after the company named chief operating officer Mark Alles as chief executive effective March 1, and cut its outlook for 2015. 12 January 2016
Cytos Biotechnology on Friday said the company will be renamed Kuros Biosciences Ltd and that its chief executive Christian Itin will be stepping down from his position. 8 January 2016
Allogeneic CAR T-cell therapies specialist Cellectis has announced the appointment of Loan Hoang-Sayag to the role of chief medical officer. 8 January 2016
KaloBios Pharmaceuticals, which fired its controversial chief executive Martin Shkreli earlier this month, yesterday announced that, on December 28, 2015, the company submitted a request to Nasdaq requesting an appeal of Nasdaq's decision to delist the company's securities. 30 December 2015
Dutch human gene therapy specialist uniQure NV has named Dan Soland its chief executive officer. He will succeed Jörn Aldag, who will step down from the role he has held since 2009. 21 December 2015
F-star, a biotech company originally founded in Vienna but now mainly based in the UK, has appointed Neil Brewis as chief scientific officer. 2 November 2015